Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LO2A in moderate to severe conjunctivochalasis
NCT02804191Phase 2Completed
- Start
- Jul 2016
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of artificial tears + corticosteroid drops in conjunctivochalasis (CCH). Started Jul 2016; status: completed.
02
Drugs
artificial tears + corticosteroid drops
03
Conditions
conjunctivochalasis (CCH)
Beyond the preview
Go deeper on NCT02804191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02804191.